The nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression

Kurzanzeige
dc.contributor.authorSauer, Heinrich
dc.contributor.authorKampmann, Henning
dc.contributor.authorKhosravi, Farhad
dc.contributor.authorSharifpanah, Fatemeh
dc.contributor.authorWartenberg, Maria
dc.date.accessioned2022-09-05T10:00:07Z
dc.date.available2022-09-05T10:00:07Z
dc.date.issued2021
dc.identifier.urihttps://jlupub.ub.uni-giessen.de//handle/jlupub/7373
dc.identifier.urihttp://dx.doi.org/10.22029/jlupub-6824
dc.language.isoen
dc.rightsNamensnennung - Nicht kommerziell 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.ddcddc:610
dc.titleThe nicotinamide phosphoribosyltransferase antagonist FK866 inhibits growth of prostate tumour spheroids and increases doxorubicin retention without changes in drug transporter and cancer stem cell protein expression
dc.typearticle
local.affiliationFB 11 - Medizin
local.source.epage434
local.source.journaltitleClinical and experimental pharmacology and physiology
local.source.spage422
local.source.urihttps://doi.org/10.1111/1440-1681.13452
local.source.volume48

Dateien

Originalbündel
Gerade angezeigt 1 - 1 von 1
Vorschaubild
Name:
10.1111_1440-1681.13452.pdf
Größe:
2.18 MB
Format:
Adobe Portable Document Format
Beschreibung:
Herunterladen

Sammlungen

Publikationen im Open Access gefördert durch die UB